ATTI 80° CONGRESSO NAZIONALE SIML
Vol. 39 No. 3 (2017)
https://doi.org/10.4081/gimle.636

[The Istituto Superiore di Sanità's focus on gender differences in the prevention and promotion of workers' health]

L’attenzione dell’Istituto Superiore di Sanità alle differenze di sesso/genere nella prevenzione e promozione della salute dei lavoratori

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 3 March 2025
88
Views
72
Downloads

Authors

Anna Ruggieri
anna.ruggieri@iss.it
Centro di Riferimento per la Medicina di Genere, Istituto Superiore di Sanità, Rome, Italy.
Elisabetta Straface
Centro di Riferimento per la Medicina di Genere, Istituto Superiore di Sanità, Rome, Italy.
Eugenio Sorrentino
Centro di Riferimento per la Medicina di Genere, Istituto Superiore di Sanità, Rome, Italy.

Gender medicine is a multi-faceted field of investigation integrating various aspects of psycho-social and biological sciences but it mainly deals with the impact of the gender on human physiology, pathophysiology, and clinical features of diseases. In Italy, the Decree Law 81/2008 recently introduced the gender issue in the risk assessment at the workplaces. This review briefly describes our current knowledge on gender medicine and on the Italian legislation in risk management. Public or private scientific institutions should be the first to pay attention to the safety of their workers, who are simultaneously subjected to biological, chemical and physical agents. The Istituto Superiore di Sanità (ISS) is beginning a project funded by INAIL, to monitor the hepatitis B, measles, rubella, mumps, pertussis, chickenpox, tetanus vaccines immune coverage in health care workers in Italy.
The analysis of the collected data will be disaggregated for men and women and statistically analyzed with respect to the time intervals from vaccination. The results could provide useful elements to implement prevention and health surveillance programs in occupational medicine.

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC
1) Klein SL, Flanagan KL. Sex differences in immune responses. Nature Rev Immunology 2016; 16: 626-638 2) Klein SL, Jedlicka A, Pekosz A. The Xs and Y of immune responses to viral vaccines. The Lancet 2010; 10: 338-349. DOI: https://doi.org/10.1038/nri.2016.90
3) Yang S, Tian G, Cui Y, Ding C, Deng M, Yu C, Xu K, Ren J, Yao J, Li Y, Cao Q, Chen P, Xie T, Wang C, Wang B, Mao C, Ruan B, Jiang T, Li L. Factor influencing immunologic response to hepatitis B vaccine in adults. Sci Rep 2016; 6: 1-12. DOI: https://doi.org/10.1038/srep27251
4) Ruggieri A, Malorni W, Ricciardi W. Gender disparity in response to anti-viral vaccines: new clues toward personalized vaccinology. Ital J Gender-Specific Med 2016; 2(3): 93-98 5) Molstad P. Coronary heart disease in women: less extensive disease and improved long-term survival compared to men. Scandinavian Cardiovascular Journal 2009; 43: 10-16. DOI: https://doi.org/10.1080/14017430802455833
6) Kannel WB. The Framingham Study: historical insight on the impact of cardiovascular risk factors in men versus women. Journal of Gender-Specific Medicine 2002; 5: 27-37.
7) Pierdominici M, Ortona E, Franconi, Caprio M, Straface E, Malorni W. Gender specific aspects of cell death in the cardiovascular system. Curr Phar Des 2011; 17: 1046-1055. DOI: https://doi.org/10.2174/138161211795656891
8) Reuben SH for The President's Cancer Panel. 2008-2009 Annual Report in President's Cancer Panel Reducing Environmental Cancer Risk. What We Can Do Now? April 2010.U.S. Department of Health and Human Services National Institutes of Health National Cancer Institute.
9) Ruggieri A, Barbati C, Malorni W. Cellular and molecular mechanisms involved in hepatocellular carcinoma gender disparity. Int J Cancer 2010; 127: 499-504. DOI: https://doi.org/10.1002/ijc.25298
10) Esser MT, Marchese RD, Kierstead LS, Tussey LG, Wang F, Chirmule N, Washabaugh MW. Memory T cells and vaccines. Vaccine 2003: 21:419-430. DOI: https://doi.org/10.1016/S0264-410X(02)00407-3
11) Agenzia Italiana del Farmaco (AIFA) Rapporto sulla sorveglianza Postmarketing dei vaccini in Italia Anno 2013.
12) ECDC Annual epidemiological report 2014 on vaccine-preventable diseases.
13) Kraemer HC (1992). Reporting the size of effects in research studies to facilitate assessment of practical or clinical significance. Psychoneuroendocrinology 1992; 17; 527-536. DOI: https://doi.org/10.1016/0306-4530(92)90013-W
14) Zaffina S, Marcellini V, Santoro AP, Scarsella M, Camisa V, Vinci MR, Musolino AM, Nicolosi L, Rosado MM, Carsetti R. Repeated vaccinations do not improve specific immune defenses against Hepatitis B in non-responder health care workers. Vaccine 2014; 32: 6902-6910. DOI: https://doi.org/10.1016/j.vaccine.2014.10.066
15) Aranburu A, Piano Mortari E, Baban A, Giorda E, Cascioli S, Marcellini V, Scarsella M, Ceccarelli S, Corbelli S, Cantarutti N, De Vito R, Inserra A, Nicolosi L, Lanfranchi A, Porta F, Cancrini C, Finocchi A, Carsetti R. Human B-cell memory is shaped by age- and tissue-specific T-independent and GC-dependent events. Eur JImmunol 2017; 47: 327-344. DOI: https://doi.org/10.1002/eji.201646642

How to Cite



1.
[The Istituto Superiore di Sanità’s focus on gender differences in the prevention and promotion of workers’ health]: L’attenzione dell’Istituto Superiore di Sanità alle differenze di sesso/genere nella prevenzione e promozione della salute dei lavoratori. G Ital Med Lav Ergon [Internet]. 2025 Mar. 3 [cited 2026 Apr. 19];39(3):218-20. Available from: https://medicine.pagepress.net/gimle/article/view/636
Copyright (c) 2017 The Author(s) Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.